s6y
Company name or ticker
Search
Cascadian Therapeutics, Inc.
4
Myers Scott Dunseth: Statement of changes in beneficial ownership of securities
Filed
Tuesday, March 21, 2017
Period
Mar 20, 2017
Accession number
0001209191-17-022141
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header